Cargando…

Predicting SARS-CoV-2 Asymptomatic Infection Rate of Inpatients: A Time Series Analysis

Background: Asymptomatic SARS-CoV-2 infections play a crucial role in viral transmission. However, they are often difficult to identify given that widespread surveillance has not been the norm. We sought to determine whether COVID-19 rates reported at the county level could predict the positivity ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera, Frida, Woo Ahn, Kwang, Silvia Munoz-Price, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551516/ http://dx.doi.org/10.1017/ash.2021.99

Ejemplares similares

Characteristics of Inpatients with False-Negative SARS-CoV-2 PCR Test Results
por: Kraft, Antigone, et al.
Publicado: (2021)

Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report
por: Patrocínio de Jesus, Rita, et al.
Publicado: (2020)

SARS-CoV-2 transmission by asymptomatic healthcare workers positive to screening swab: an Italian study
por: Palese, Francesca, et al.
Publicado: (2022)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

Analysis of Universal admission laboratory screening for SARS-CoV-2 asymptomatic infection across a large health system
por: Cihlar, Jennifer, et al.
Publicado: (2022)

Time-varying Reproductive Rates for SARS-CoV-2 and its Implications as a Means of Disease Surveillance on Lockdown Restrictions
por: Toraih, Eman A., et al.
Publicado: (2021)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

Postoperative Onset and Detection of SARS-CoV-2 in Surgically Resected Specimens From Gastrointestinal Cancer Patients With Pre/Asymptomatic COVID-19
por: Liu, Yan-Liang, et al.
Publicado: (2020)

Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: A retrospective, multicenter study
por: Weitzner, Zachary N., et al.
Publicado: (2022)

Low infectivity among asymptomatic patients with a positive SARS-CoV-2 admission test at a tertiary-care center, 2020–2022
por: Tayyar, Ralph, et al.
Publicado: (2023)

Sociodemographic Factors, Cycle Threshold Values, and Clinical Outcomes of COVID-19
por: Rivera, Frida, et al.
Publicado: (2021)

Acute Polyneuropathy in an Outpatient Context During the SARS-CoV-2 Pandemic: A Brief Case Serie Report
por: de Francisco Moure, Jorge, et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

SG-APSIC1126: Controlling SARS-CoV-2 infection in inpatients through a grouping system at Ho Chi Minh Children’s Hospital 1 in Vietnam
por: Minh, Chau Nguyen Ngoc, et al.
Publicado: (2023)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Comparing SARS-CoV-2 case rates between pupils, teachers and the general population: results from Germany
por: Koestner, Clemens, et al.
Publicado: (2021)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey
por: Mutevedzi, Portia Chipo, et al.
Publicado: (2021)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Statistical Deconvolution for Inference of Infection Time Series
por: Miller, Andrew C., et al.
Publicado: (2022)

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis
por: Hada, Manila, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Improved assay for detecting SARS-CoV-2 from nonporous hospital surfaces using surrogate human coronavirus OC43
por: Tran, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5bdnjkj8ngsroq853tnk1idpb